Skip to content

RVMDW

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$9.76
−5.20%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$2.41
Revenue estimate
$19.4M

Latest reported

Last report date
Aug 5, 2026
EPS actual
-$3.06
EPS estimate
-$2.04
Revenue actual
Revenue estimate
$1.8M

Track record

Trailing twelve quarters

EPS beats (12Q)
0
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
-37.4%
Revenue beats (12Q)
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 5, 2026-$2.04-$3.06Miss -49.81%
May 6, 2026-$1.84-$2.29Miss -24.75%
Feb 25, 2026-$1.58-$2.18Miss -37.57%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026